Spero Therapeutics logo
Spero Therapeutics SPRO
€ 0.67 -9.76%
report update icon

Quartalsbericht 2026-Q3
hinzugefügt 12.11.2026

Spero Therapeutics Gesamtes Eigenkapital | SPRO

Gesamtes Eigenkapital Jährlich Spero Therapeutics

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
59 M 46.1 M 107 M 75.9 M 88.3 M 132 M 74.6 M 116 M 84.6 M -49.2 M -18.6 M - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
132 M -49.2 M 65 M

Gesamtes Eigenkapital Vierteljährlich Spero Therapeutics

2026-Q3 2026-Q2 2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
781 K 44.2 M 52.9 M 59 M 26.5 M 32.8 M 33.8 M 46.1 M 65.5 M 80.5 M 96.2 M 107 M 53.7 M 54.8 M 64.8 M 75.9 M 32.5 M 35.9 M 62.5 M 88.3 M 112 M 90.3 M 119 M 132 M 133 M 73.7 M 132 M 74.6 M 93 M 110 M 113 M 116 M 126 M 65.7 M 74.9 M 85 M -81.8 M 84.6 M 84.6 M -45.4 M -45.4 M - - -18.6 M - - - -6.11 M - - - - - - - - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert Mindestwert Durchschnitt
133 M -81.8 M 63.6 M

Gesamtes Eigenkapital anderer Aktien in der Pharmaeinzelhändler

Name Gesamtes Eigenkapital Preis % 24h Marktkapitalisierung Land
Rubius Therapeutics Rubius Therapeutics
RUBY
15.1 M - -33.55 % $ 7.81 M usaUSA
Mirati Therapeutics Mirati Therapeutics
MRTX
997 M - - $ 3.3 B usaUSA
InVivo Therapeutics Holdings Corp. InVivo Therapeutics Holdings Corp.
NVIV
15.7 M - -37.48 % $ 476 K usaUSA
Bellicum Pharmaceuticals Bellicum Pharmaceuticals
BLCM
2.02 M - -9.72 % $ 5.89 M usaUSA
Orchard Therapeutics plc Orchard Therapeutics plc
ORTX
98.3 M - 1.02 % $ 90.8 M britainBritain
La Jolla Pharmaceutical Company La Jolla Pharmaceutical Company
LJPC
-66.7 M - - $ 154 M usaUSA
Oyster Point Pharma Oyster Point Pharma
OYST
99.5 M - - $ 300 M usaUSA
Intercept Pharmaceuticals Intercept Pharmaceuticals
ICPT
93.1 M - - $ 643 M usaUSA
Chinook Therapeutics Chinook Therapeutics
KDNY
442 M - - $ 2.6 B usaUSA
Syros Pharmaceuticals Syros Pharmaceuticals
SYRS
16.7 M - -8.44 % $ 3.4 M usaUSA
NanoViricides NanoViricides
NNVC
8.68 M $ 1.15 -2.54 % $ 23.2 M usaUSA
GT Biopharma GT Biopharma
GTBP
5.79 M $ 2.93 -7.86 % $ 16.2 M usaUSA
Zymeworks Zymeworks
ZYME
249 M $ 26.41 -1.68 % $ 1.36 B canadaCanada
Aldeyra Therapeutics Aldeyra Therapeutics
ALDX
44.3 M $ 0.84 16.41 % $ 50.4 M usaUSA
Citius Pharmaceuticals Citius Pharmaceuticals
CTXR
67.6 M $ 0.51 1.61 % $ 5.64 M usaUSA
Cytokinetics, Incorporated Cytokinetics, Incorporated
CYTK
-660 M $ 50.7 -1.48 % $ 6.09 M usaUSA
DBV Technologies S.A. DBV Technologies S.A.
DBVT
169 M $ 9.03 -4.14 % $ 1.26 B franceFrance
Precision BioSciences Precision BioSciences
DTIL
92.2 M $ 7.37 6.66 % $ 94.5 M usaUSA
Exelixis Exelixis
EXEL
2.16 B $ 64.59 -1.88 % $ 17.5 B usaUSA
Fennec Pharmaceuticals Fennec Pharmaceuticals
FENC
35.5 M $ 13.09 -2.68 % $ 374 M usaUSA
Cardiff Oncology Cardiff Oncology
CRDF
45.4 M $ 0.85 -4.67 % $ 56.8 M usaUSA
BioNTech SE BioNTech SE
BNTX
19.2 B $ 80.87 -0.63 % $ 19.5 B germanyGermany
Alkermes plc Alkermes plc
ALKS
1.82 B $ 44.89 -2.79 % $ 7.39 B irlandaIrlanda
ANI Pharmaceuticals ANI Pharmaceuticals
ANIP
541 M $ 68.6 -0.77 % $ 1.38 B usaUSA
AIM ImmunoTech AIM ImmunoTech
AIM
-9.78 M $ 0.11 -7.75 % $ 178 K usaUSA
AC Immune SA AC Immune SA
ACIU
44.9 M $ 1.98 -7.28 % $ 199 M schweizSchweiz
Atara Biotherapeutics Atara Biotherapeutics
ATRA
-38.5 M $ 6.51 2.6 % $ 81.7 M usaUSA
Allogene Therapeutics Allogene Therapeutics
ALLO
293 M $ 0.63 -5.62 % $ 139 M usaUSA
Altimmune Altimmune
ALT
225 M $ 1.33 -6.03 % $ 117 M usaUSA
AnaptysBio AnaptysBio
ANAB
10.6 M $ 46.65 -1.58 % $ 1.35 B usaUSA
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
-163 M $ 252.39 -1.39 % $ 15.3 B danmarkDanmark
Arcturus Therapeutics Holdings Arcturus Therapeutics Holdings
ARCT
214 M $ 7.42 -2.37 % $ 203 M israelIsrael
Aurinia Pharmaceuticals Aurinia Pharmaceuticals
AUPH
581 M $ 14.7 -1.28 % $ 1.98 B canadaCanada
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
178 M $ 0.91 -6.96 % $ 242 M britainBritain
Atea Pharmaceuticals Atea Pharmaceuticals
AVIR
275 M $ 3.97 0.89 % $ 324 M usaUSA
Axsome Therapeutics Axsome Therapeutics
AXSM
88.3 M $ 129.32 -4.69 % $ 6.43 B usaUSA
BridgeBio Pharma BridgeBio Pharma
BBIO
-2.09 B $ 75.96 -2.84 % $ 14.5 B usaUSA
BioCryst Pharmaceuticals BioCryst Pharmaceuticals
BCRX
-119 M $ 7.23 -1.3 % $ 1.52 B usaUSA
Bicycle Therapeutics plc Bicycle Therapeutics plc
BCYC
610 M $ 2.89 -5.25 % $ 200 M britainBritain
Benitec Biopharma Benitec Biopharma
BNTC
177 M $ 7.95 -2.4 % $ 370 M usaUSA
DiaMedica Therapeutics DiaMedica Therapeutics
DMAC
56.1 M $ 8.24 2.74 % $ 387 M usaUSA
Insmed Incorporated Insmed Incorporated
INSM
739 M $ 141.06 -2.35 % $ 28.1 B usaUSA
Iovance Biotherapeutics Iovance Biotherapeutics
IOVA
699 M $ 6.9 -5.61 % $ 2.47 M usaUSA
CollPlant Biotechnologies Ltd. CollPlant Biotechnologies Ltd.
CLGN
6.08 M $ 4.64 17.17 % $ 56.6 M israelIsrael
InMed Pharmaceuticals InMed Pharmaceuticals
INM
1.08 M $ 15.56 13.57 % $ 64.8 M canadaCanada
Biohaven Pharmaceutical Holding Company Ltd. Biohaven Pharmaceutical Holding Company Ltd.
BHVN
-739 M $ 12.36 -9.55 % $ 799 M usaUSA
Immutep Limited Immutep Limited
IMMP
144 M $ 3.11 -9.06 % $ 4.53 B australiaAustralia
Jazz Pharmaceuticals plc Jazz Pharmaceuticals plc
JAZZ
4.32 B $ 228.26 -3.46 % $ 13.9 B irlandaIrlanda
BeyondSpring BeyondSpring
BYSI
-32.2 M $ 0.33 -24.42 % $ 13.6 M usaUSA